Skip to main content

Select Drug Profiles

Dermatology, Perspectives

Soolantra (Ivermectin) 1% Cream: A Novel, Antibiotic-Free Agent Approved for the Treatment of Patients with Rosacea

Lisa A. Raedler, PhD, RPh

David B. Nash, MD, MBA

Key Strategic Trends that Impact Healthcare Decision-Making and Stakeholder Roles in the New Marketplace

John Santilli, MBA, F. Randy Vogenberg, PhD, FASHP

Original Research

Is Response-Guided Therapy Being Applied in the Clinical Setting? The Hepatitis C Example

Jennifer B Harris, PharmD, Phil Schwab, PhD, Melea A. Ward, PharmD, MS

Stakeholder Perspective

Response-Guided Therapy an Appropriate Tool for Evaluating Treatment Protocols and Costs of Drug Therapies

by Jack E. Fincham, PhD, RPh

Diagnosis and Treatment of Patients with Thyroid Cancer

Melinda G Huang, Aashish Khullar, MD, Eun Joo Lee, Quang T. Nguyen, DO, FACE, FTOS, Young In Park, DO, Raymond A. Plodkowski, MD

Stakeholder Perspective

Predictive Models and Technology Present Opportunities to Support Early Diagnosis, Treatment, and Adherence to Guidelines

by Jeffrey A. Bourret, PharmD

Faculty Perspectives: Prevalence, Burden, Epidemiology, and Pathophysiology of Asthma

Expectations of value-based cancer care

Michael Kolodziej, MD

Data to show impacts on collaborative approach to improve patient outcomes

Michael Kolodziej, MD

Payer/provider downside risk

Michael Kolodziej, MD

Payer/provider colaborations

Michael Kolodziej, MD

Page 140 of 244
Results 1391 - 1400 of 2434